MRNA therapy at the convergence of genetics and nanomedicine.

Abstract

Since the early 1990s, the intersection of genetics and nanomedicine has found a home in the clinic as one of the game changers of the past decade, holding great promise in fighting diseases by rapidly developing much-needed therapeutic platforms, from cancer to infectious or genetic diseases. And this revolution was just triggered by the amazing evolving world of messenger RNA and its ‘cues’.